Drug, Device Cos. Assail FDA's Off-Label Stance
Top drug and device makers are strongly pressuring the U.S. Food and Drug Administration to dial back new policies regarding off-label promotion, calling them wildly overbroad, letters released Wednesday show....To view the full article, register now.
Already a subscriber? Click here to view full article